Moss, 15 November 2017
Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:
- 66% growth in sales revenue compared to 3Q16, 16 % y/y
- New patent protection received after end of period
Please find the report for the third quarter enclosed.
For further information, please contact:
Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117
MeldingsID: 438711
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: HALVÅRSRAPPORTER OG REVISJONSBERETNINGER / UTTALELSER OM FORENKLET REVISORKONTROLL